The business specialises in low-cost medical technology such as its flagship 3nethra platform, which can be used to detect a range of eye diseases and defects with minimal technical help.
Forus said it would use the Series A funding to develop technologies to solve healthcare delivery problems, drive manufacturing and perform R&D on new products.
IDG Ventures India president Ranjith Menon said, “We are always interested in platform technologies that can deliver healthcare cost effectively.
“The pre-screening technology developed by Forus holds tremendous potential and will help address issues relating to avoidable blindness globally.”
Forus previously failed to raise a $3m tranche by November last year, but has now beaten that target through Accel and IDG’s investment.
Forus president and CTO Shyam Vasudeva Rao said, “Technology can help us rethink healthcare delivery, and perhaps technology can transform healthcare from being cure-centric to prevention-centric and hence have a deeper impact in people’s lives.
“We will focus on developing technologies for early screening which will help the doctors to focus on needy patients only.”
Copyright © 2011 AltAssets